drugset / Trial / NCT00143481

Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

NCT00143481

Phase 4 Completed 400 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the impact of treatment with tolterodine ER versus placebo on Urgency Urinary Incontinence in sexually active women with OAB symptoms.

Timeline

Start
2005-03
Primary completion
2006-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolterodine Small molecule 4 mg

Indications